Stockreport

Pliant Therapeutics to Participate in Upcoming Investor Conferences

Pliant Therapeutics, Inc.  (PLRX) 
PDF SOUTH SAN FRANCISCO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the disco [Read more]